BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35338033)

  • 1. Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
    Choi MY; Clarke AE; Urowitz M; Hanly J; St-Pierre Y; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Wallace DJ; Isenberg D; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; Alarcón GS; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian K; Jacobsen S; Peschken C; Kamen DL; Askanase A; Buyon JP; Costenbader KH; Fritzler MJ
    Ann Rheum Dis; 2022 Aug; 81(8):1143-1150. PubMed ID: 35338033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease.
    Frodlund M; Wetterö J; Dahle C; Dahlström Ö; Skogh T; Rönnelid J; Sjöwall C
    Clin Exp Immunol; 2020 Mar; 199(3):245-254. PubMed ID: 31778219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different indirect immunofluorescence ANA substrate performance in a diagnostic setting of patients with SLE and related disorders: retrospective review and analysis.
    Choi MY; Cui J; Costenbader K; Rydzewski D; Bernhard L; Schur P
    Lupus Sci Med; 2020 Nov; 7(1):. PubMed ID: 33154098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative ANA-IIF in SLE patients: what is beyond?
    Abozaid HSM; Hefny HM; Abualfadl EM; Ismail MA; Noreldin AK; Eldin ANN; Goda AM; Ali AH
    Clin Rheumatol; 2023 Jul; 42(7):1819-1826. PubMed ID: 37016193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modern look at the problems of investigation of antinuclear antibodies in systemic lupus erythematosus (literature review).].
    Aleksandrova EN; Verizhnikova ZG; Novikov AA; Lukina GV
    Klin Lab Diagn; 2018; 63(6):340-348. PubMed ID: 30702224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of anti-nuclear antibody by immunofluorescence assay and enzyme immunoassay in childhood systemic lupus erythematosus: experience from Bangladesh.
    Dipti TR; Azam MS; Sattar MH; Rahman SA
    Int J Rheum Dis; 2012 Feb; 15(1):121-5. PubMed ID: 22324956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [THE CLINICAL INFORMATIVENESS OF AUTOMATED METHODS OF SCREENING DETECTION OF ANTI-NUCLEAR ANTIBODIES USING INDIRECT REACTION OF IMMUNE FLUORESCENCE, ENZYME-LINKED IMMUNOSORBENT ASSAY AND MULTIPLEX XMAP TECHNOLOGY UNDER SYSTEMIC LUPUS ERYTHEMATOSUS].
    Verizhnikova ZG; Aleksandrova EN; Novikov AA; Panafidina TA; Seredavkina NV; Popkova TV; Aizina NL; Nasonov EL
    Klin Lab Diagn; 2017 Mar; 62(3):173-7. PubMed ID: 30620533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous Lupus Erythematosus Patients With a Negative Antinuclear Antibody Meeting the American College of Rheumatology and/or Systemic Lupus International Collaborating Clinics Criteria for Systemic Lupus Erythematosus.
    Tarazi M; Gaffney RG; Kushner CJ; Chakka S; Werth VP
    Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1404-1409. PubMed ID: 31058462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
    Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
    Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of laboratory tests in the diagnosis of SLE.
    Egner W
    J Clin Pathol; 2000 Jun; 53(6):424-32. PubMed ID: 10911799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay variation in the detection of antinuclear antibodies in the sera of patients with established SLE.
    Pisetsky DS; Spencer DM; Lipsky PE; Rovin BH
    Ann Rheum Dis; 2018 Jun; 77(6):911-913. PubMed ID: 29440000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANA as an entry criterion for the classification of SLE.
    Pisetsky DS; Bossuyt X; Meroni PL
    Autoimmun Rev; 2019 Dec; 18(12):102400. PubMed ID: 31639513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the result of antinuclear antibody immunofluorescence assay on HEp-2 cells reflect disease activity status in systemic lupus erythematosus.
    Prado MS; Dellavance A; Rodrigues SH; Marvulle V; Andrade LEC
    Clin Chem Lab Med; 2020 Jul; 58(8):1271-1281. PubMed ID: 32623848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-dsDNA antibodies in systemic lupus erythematosus: A combination of two quantitative methods and the ANA pattern is the most efficient strategy of detection.
    Almeida González D; Roces Varela A; Marcelino Rodríguez I; González Vera A; Delgado Sánchez M; Aznar Esquivel A; Casañas Rodríguez C; Cabrera de León A
    J Immunol Methods; 2015 Dec; 427():30-5. PubMed ID: 26407840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of chemiluminescence microparticle immunoassay, indirect immunofluorescence assay, linear immunoassay and multiple microbead immunoassay detecting autoantibodies in systemic lupus erythematosus.
    Wei Q; Jiang Y; Xiao M; Zhang X; Qi J; Xie J; Wu J; Wu Z; Gu J
    Scand J Immunol; 2020 Mar; 91(3):e12849. PubMed ID: 31899559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patients: a community based approach.
    Laustrup H; Heegaard NH; Voss A; Green A; Lillevang ST; Junker P
    Lupus; 2004; 13(10):792-9. PubMed ID: 15540512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis.
    Copple SS; Sawitzke AD; Wilson AM; Tebo AE; Hill HR
    Am J Clin Pathol; 2011 May; 135(5):678-84. PubMed ID: 21502422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinuclear antibody screening by ELISA and IF techniques: discrepant results in juvenile idiopathic arthritis but consistency in childhood systemic lupus erythematous.
    Spârchez M; Delean D; Samaşcă G; Miu N; Spârchez Z
    Clin Rheumatol; 2014 May; 33(5):643-7. PubMed ID: 24557079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
    Urowitz MB; Gladman DD; Ibañez D; Fortin PR; Bae SC; Gordon C; Clarke A; Bernatsky S; Hanly JG; Isenberg D; Rahman A; Sanchez-Guerrero J; Wallace DJ; Ginzler E; Alarcón GS; Merrill JT; Bruce IN; Sturfelt G; Nived O; Steinsson K; Khamashta M; Petri M; Manzi S; Ramsey-Goldman R; Dooley MA; van Vollenhoven RF; Ramos M; Stoll T; Zoma A; Kalunian K; Aranow C
    Arthritis Care Res (Hoboken); 2012 Jan; 64(1):132-7. PubMed ID: 21954226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.
    Choi MY; Clarke AE; St Pierre Y; Hanly JG; Urowitz MB; Romero-Diaz J; Gordon C; Bae SC; Bernatsky S; Wallace DJ; Merrill JT; Isenberg DA; Rahman A; Ginzler EM; Petri M; Bruce IN; Dooley MA; Fortin PR; Gladman DD; Sanchez-Guerrero J; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Alarcón GS; Manzi S; Nived O; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Stoll T; Buyon J; Mahler M; Fritzler MJ
    Arthritis Care Res (Hoboken); 2019 Jul; 71(7):893-902. PubMed ID: 30044551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.